---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-056983"
form_type: "8-K"
ticker: "CUE"
cik: "0001645460"
company_name: "Cue Biopharma, Inc."
filed_at: "2026-02-18T23:59:59+00:00"
generated_at: "2026-05-16T02:05:23.942978+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Cue Biopharma sets 2026 annual meeting for April 13; shareholder deadlines on Feb 28.

## Summary
- Annual meeting date: April 13, 2026.
- Shareholder proposals under Rule 14a-8 must be received by February 28, 2026.
- Director nominations and other business also due by February 28, 2026 per Bylaws and Rule 14a-19.
- Proxies may exercise discretionary voting on late proposals.

## SEC filing metadata
- accession: 0001193125-26-056983
- form_type: 8-K
- ticker: CUE
- cik: 0001645460
- company_name: Cue Biopharma, Inc.
- filed_at: 2026-02-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645460/000119312526056983/0001193125-26-056983-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645460/000119312526056983/cue-20260218.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-056983
- JSON: https://secwatch.observer/filing/0001193125-26-056983.json
- Plain text: https://secwatch.observer/filing/0001193125-26-056983.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.